(Photo: iStock)

The Department of Health and Social Care (DH) on Monday (November 30) has released the final drug price concessions list for November 2020.

The final list of drugs includes the following…

Drug Pack Size Price Concession
Alendronic acid 10mg tablets 28 £6.60
Duloxetine 40mg gastro-resistant capsules 56 £13.96
Entacapone 200mg tablets 30 £9.95
Esomeprazole 40mg gastro-resistant capsules 28 £4.76
Lamotrigine 200mg tablets 56 £5.52
Lamotrigine 25mg tablets 56 £2.07
Naftidrofuryl 100mg capsules 84 £7.35
Olanzapine 10mg tablets 28 £2.46
Prednisolone 1mg gastro-resistant tablets 30 £6.48
Sulfasalazine 500mg gastro-resistant tablets 112 £11.96
Tamoxifen 20mg tablets 30 £11.48
Zonisamide 100mg capsules 56 £62.72

 

Second drug price concession list released on November 23

Drug Pack Size Price Concession
Desmopressin 10micrograms/dose nasal spray 60 dose £22.81
Docusate 100mg capsules 30 £3.20
Olmesartan medoxomil 40mg tablets 28 £3.46
Prochlorperazine 5mg tablets 28 £1.49
Senna 7.5mg tablets 60 £2.76
Sulfasalazine 500mg tablets 112 £6.88

 

First drug price concessions list released on November 17

Drug Pack Size Price Concession
Ciprofloxacin 250mg tablets 10 £1.95
Ciprofloxacin 500mg tablets 10 £5.52
Duloxetine 20mg gastro-resistant capsules 28 £9.98
Duloxetine 30mg gastro-resistant capsules 28 £2.37
Duloxetine 60mg gastro-resistant capsules 28 £4.56
Enalapril 10mg tablets 28 £4.99
Enalapril 20mg tablets 28 £10.20
Esomeprazole 20mg gastro-resistant tablets 28 £3.99
Hydrocortisone 2.5% cream 15g £44.00
Irbesartan 300mg / Hydrochlorothiazide 12.5mg tablets 28 £14.31
Lamotrigine 100mg tablets 56 £6.18
Lamotrigine 50mg tablets 56 £4.80
Moxonidine 200microgram tablets 28 £9.10
Moxonidine 300microgram tablets 28 £10.50
Moxonidine 400microgram tablets 28 £8.16
Olanzapine 15mg tablets 28 £4.20
Olanzapine 20mg tablets 28 £4.97
Oxytetracycline 250mg tablets 28 £8.31
Rasagiline 1mg tablets 28 £10.05

If you want to share your stories and/or experiences with us, please send an email to [email protected]

LEAVE A REPLY